§ 13F · FUND PROFILE
Lion Point Capital, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 39Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$19.3T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | MIST | MILESTONE PHARMACEUTICALS IN | 755K | $1.5T | 7.9% | NEW |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | 4K | $1.3T | 6.8% | NEW |
| 3 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 68K | $889.6B | 4.6% | NEW |
| 4 | FENC | FENNEC PHARMACEUTICALS INC | 112K | $865.7B | 4.5% | NEW |
| 5 | JSPR | JASPER THERAPEUTICS INC | 465K | $851.0B | 4.4% | NEW |
| 6 | BNTC | BENITEC BIOPHARMA INC | 62K | $835.1B | 4.3% | NEW |
| 7 | RPRX | ROYALTY PHARMA PLC | 21K | $826.9B | 4.3% | NEW |
| 8 | GERN | GERON CORP | 578K | $763.0B | 3.9% | NEW |
| 9 | SNDX | SYNDAX PHARMACEUTICALS INC | 36K | $756.4B | 3.9% | NEW |
| 10 | ARDX | ARDELYX INC | 129K | $750.0B | 3.9% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE LION SIGNAL
AC read
Lion Point Capital, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed